Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.
2.

Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.

Gray SA, Moore M, VandenEkart EJ, Roque RP, Bowen RA, Van Hoeven N, Wiley SR, Clegg CH.

Antiviral Res. 2016 Jul;131:100-8. doi: 10.1016/j.antiviral.2016.04.001. Epub 2016 Apr 21.

3.

Targeting TLRs expands the antibody repertoire in response to a malaria vaccine.

Wiley SR, Raman VS, Desbien A, Bailor HR, Bhardwaj R, Shakri AR, Reed SG, Chitnis CE, Carter D.

Sci Transl Med. 2011 Jul 27;3(93):93ra69. doi: 10.1126/scitranslmed.3002135.

4.

Development of a spiritually based educational program to increase colorectal cancer screening among African American men and women.

Holt CL, Roberts C, Scarinci I, Wiley SR, Eloubeidi M, Crowther M, Bolland J, Litaker MS, Southward V, Coughlin SS.

Health Commun. 2009 Jul;24(5):400-12. doi: 10.1080/10410230903023451.

PMID:
19657823
5.

TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.

Wiley SR, Winkles JA.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. Review.

PMID:
12787562
6.

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.

Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC.

Immunity. 2001 Nov;15(5):837-46.

7.

IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.

Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D, Wiley SR.

J Immunol. 1999 Jul 15;163(2):920-6.

8.

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA.

J Exp Med. 1999 Apr 19;189(8):1343-54.

9.

Genomics in the real world.

Wiley SR.

Curr Pharm Des. 1998 Oct;4(5):417-22. Review.

PMID:
10197053
10.

TWEAK induces angiogenesis and proliferation of endothelial cells.

Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, Wiley SR.

J Biol Chem. 1999 Mar 26;274(13):8455-9.

11.

Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements.

Johnston SD, Liu X, Zuo F, Eisenbraun TL, Wiley SR, Kraus RJ, Mertz JE.

Mol Endocrinol. 1997 Mar;11(3):342-52.

PMID:
9058380
12.

Reverse signaling via CD30 ligand.

Wiley SR, Goodwin RG, Smith CA.

J Immunol. 1996 Oct 15;157(8):3635-9.

PMID:
8871664
13.

Experimentally determined weight matrix definitions of the initiator and TBP binding site elements of promoters.

Kraus RJ, Murray EE, Wiley SR, Zink NM, Loritz K, Gelembiuk GW, Mertz JE.

Nucleic Acids Res. 1996 Apr 15;24(8):1531-9.

14.

Identification and characterization of a new member of the TNF family that induces apoptosis.

Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, et al.

Immunity. 1995 Dec;3(6):673-82.

15.

SV40 early-to-late switch involves titration of cellular transcriptional repressors.

Wiley SR, Kraus RJ, Zuo F, Murray EE, Loritz K, Mertz JE.

Genes Dev. 1993 Nov;7(11):2206-19.

16.

Supplemental Content

Loading ...
Support Center